Subscribe


PD breaking news – Symbion to be taken over by EBOS

EBOS confirms Symbion acquisition.

Symbion Pharmacy Services is set to be acquired by NZ-based EBOS Group, in a NZ$1.1 billion transaction which “will create the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products.”

As foreshadowed in Pharmacy Daily this morning, existing Symbion management will remain in place, with ceo Patrick Davies saying the structure of the new entity further strengthens Symbion’s commitment to the Australian pharmacy industry.

“While this agreement creates an organisation that has very significant scale, resources and opportunities, it achieves this while maintaining everything that is important to our customers,” he said.

EBOS will acquire 100% of Symbion, while the Zuellig Group, which currently owns Symbion, will take a 40% shareholding of the enlarged EBOS Group.

The Symbion brand will remain in place, along with “the stable influence of the Zuellig Group as a major shareholder,” Davies said, adding that “the values and philosophies of Symbion and EBOS are very strongly aligned”.

EBOS ceo Mark Waller said the deal would be transformational for EBOS.

“This is a rare opportunity to create a clear trans-Tasman market leader,” he said.

A Special General Meeting of EBOS will take place in Christchurch on 14 June, and if all required conditions are satisfied including approval by shareholders the transaction is expected to complete in early July.

More information in Pharmacy Daily as it comes to hand.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 29 May 13

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

16 Jan

Guild Update 16 Jan 18 - MEDSASSIST - the real time recording system ...


16 Jan

Dispensary Corner 16 Jan 18 - IF IT'S true that smoking can stunt ...


16 Jan

Another AD drug fail - EVER elusive, yet another drug that showed ...


16 Jan

PBA call for board members - THE Pharmacy Board of Australia is currently ...


16 Jan

Busting for a script? - PATIENTS visiting the Chemist Warehouse pharmacy in ...


16 Jan

New Arrow items - ARROW Pharmaceuticals has announced the launch of ...


16 Jan

Blockchain an answer - TECHNOLOGY research and development standards group IEEE ...


16 Jan

Apr price disclosure - THE Therapeutic Goods Administration has published its ...


16 Jan

Rural stroke risk - NEW Australian research published in the MJA ...


16 Jan

Creso expansion - ASX-LISTED cannabis company Creso has announced its ...


16 Jan

E-cigarette research boost - IN WHAT could prove to be a ...


16 Jan

Fred IT links with AMH - FRED IT Group and the Australian Medicines ...


15 Jan

Weekly Comment 15 Jan 18 - WELCOME to PD's weekly comment feature. This ...


15 Jan

Dispensary Corner 15 Jan 18 - THE animal cuteness scale has just been ...


15 Jan

Dr shopper home-cooker arraigned - A PERTH woman, who's identity changed frequently ...


15 Jan

Brenzys guide - BIOSIMILAR Brenzys (etanercept) from MSD Australia is ...


15 Jan

Nicotine in pregnancy - NICOTINE replacement therapies such as nicotine gum ...


15 Jan

Black triangle details - THE Therapeutic Goods Administration has posted information ...


15 Jan

Nurse issued Stilnox - DAVID Cain, a credentialed mental health nurse ...


15 Jan

Pharmaceutical calcs - THE fifth edition of Pharmaceutical Calculations has ...



Show Pharmacy Daily items by month: